New therapeutics combination inhibits glioblastoma multiforme tumor growth
A study led by Nicolas Bazan, MD, Ph.D., Boyd Professor and Director of LSU Health New Orleans Neuroscience Center of Excellence, reports that in an experimental model of glioblastoma multiforme (GBM), a combination of approved ...